749. Healthcare Utilization After Hospitalization for Respiratory Syncytial Virus or Unspecified Bronchiolitis in the First Year of Life

por Ledbetter, Joel, Brannman, Lance, Wade, Sally, Diakun, David, Gonzales, Tara, Kong, Amanda
Publicado 2018

735. Severity and Healthcare Costs of Respiratory Syncytial Virus Hospitalizations in US Preterm Infants Born at 29–34 Weeks Gestation: 2014–2016

por Goldstein, Mitchell, Krilov, Leonard R, Fergie, Jaime, Ambrose, Christopher S, Wade, Sally, Kong, Amanda, Brannman, Lance
Publicado 2018

740. Impact of the 2014 American Academy of Pediatrics Guidance on Respiratory Syncytial Virus Hospitalization Rates for Preterm Infants <29 Weeks Gestational Age at Birth: 2012–20...

por Goldstein, Mitchell, Krilov, Leonard R, Fergie, Jaime, Brannman, Lance, Ambrose, Christopher S, Wade, Sally, Kong, Amanda
Publicado 2018

Update on respiratory syncytial virus hospitalizations among U.S. preterm and term infants before and after the 2014 American Academy of Pediatrics policy on immunoprophylaxis: 201...

por Fergie, Jaime, Goldstein, Mitchell, Krilov, Leonard R., Wade, Sally W., Kong, Amanda M., Brannman, Lance
Publicado 2020

Unintended Consequences Following the 2014 American Academy of Pediatrics Policy Change for Palivizumab Prophylaxis among Infants Born at Less than 29 Weeks' Gestation

por Goldstein, Mitchell, Krilov, Leonard R., Fergie, Jaime, Brannman, Lance, Wade, Sally W., Kong, Amanda M., Ambrose, Christopher S.
Publicado 2021

743. Severity and Costs of Respiratory Syncytial Virus and Bronchiolitis Hospitalization in Commercially Insured Preterm and Term Infants Before and After the 2014 American Academy...

por Krilov, Leonard R, Fergie, Jaime, Goldstein, Mitchell, Rizzo, Christopher, Brannman, Lance, McPheeters, Jeffrey, Korrer, Stephanie, Burton, Tanya, Sharpsten, Lucie
Publicado 2018

Health Equity in Patients Receiving Durvalumab for Unresectable Stage III Non-Small Cell Lung Cancer in the US Veterans Health Administration

por Moore, Amanda M, Nooruddin, Zohra, Reveles, Kelly R, Koeller, Jim M, Whitehead, Jennifer M, Franklin, Kathleen, Datta, Paromita, Alkadimi, Munaf, Brannman, Lance, Cotarla, Ion, Frankart, Andrew J, Mulrooney, Tiernan, Jones, Xavier, Frei, Christopher R
Publicado 2023

Durvalumab Treatment Patterns for Patients with Unresectable Stage III Non-Small Cell Lung Cancer in the Veterans Health Administration (VHA): A Nationwide, Real-World Study

por Moore, Amanda M., Nooruddin, Zohra, Reveles, Kelly R., Datta, Paromita, Whitehead, Jennifer M., Franklin, Kathleen, Alkadimi, Munaf, Williams, Madison H., Williams, Ryan A., Smith, Sarah, Reichelderfer, Renee, Cotarla, Ion, Brannman, Lance, Frankart, Andrew, Mulrooney, Tiernan, Hsieh, Kristin, Simmons, Daniel J., Jones, Xavier, Frei, Christopher R.
Publicado 2023

Prospective observational study in patients with obstructive lung disease: NOVELTY design

por Reddel, Helen K., Gerhardsson de Verdier, Maria, Agustí, Alvar, Anderson, Gary, Beasley, Richard, Bel, Elisabeth H., Janson, Christer, Make, Barry, Martin, Richard J., Pavord, Ian, Price, David, Keen, Christina, Gardev, Asparuh, Rennard, Stephen, Sveréus, Alecka, Bansal, Aruna T., Brannman, Lance, Karlsson, Niklas, Nuevo, Javier, Nyberg, Fredrik, Young, Simon S., Vestbo, Jørgen
Publicado 2019